Indian equity benchmarks advanced on Thursday, driven by gains in heavyweight financials, although a decline in Tata Motors ...
In an expert call, the brokerage addressed possibilities of pass-through of tariffs to consumers, and the feasibility of ...
The sector needs to clean up its act and focus on quality. It won’t until New Delhi insists on more and better regulations.
Indian pharma stocks fell for the third consecutive session amid concerns of potential US tariffs on pharmaceutical imports.
Trump to give another blow to India; set to impose tax on…, impact expected on trade worth a whopping Rs… By clicking “Accept ...
Investors in pharma and auto stocks are anxious ahead of the April 2 deadline for US tariffs. Despite a 6% fall over three ...
Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan ...
Warns that Indian pharmaceutical products could become more expensive in the US, reducing their competitiveness in one of the ...
Satyanarayana Chava of Laurus Labs stated that global pharma firms prioritise sustainability, scale, and compliance over cost ...
Hetero Group founder, B Parthasaradhi Reddy, warns of potential US reciprocal tariffs on Indian pharmaceuticals, which could disrupt India's pharma industry, leading to higher prices and reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback